Infectious Agents and Cancer
A section of Cancers (ISSN 2072-6694).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Infectious Agents and Cancer in Children and Adolescents (Deadline: 15 May 2026)
- Viral Oncogenes and Their Role in Cancer Pathogenesis (Deadline: 21 May 2026)
- Infectious Agents and Oesophageal Cancer (2nd Edition) (Deadline: 31 May 2026)
- Human Papillomavirus (HPV) and Related Cancer (Deadline: 30 June 2026)
- HIV-Associated Lymphoid Neoplasms (2nd Edition) (Deadline: 20 July 2026)
- Epstein-Barr Virus-Associated Cancers: From Pathogenesis to Treatment (2nd Edition) (Deadline: 31 July 2026)
- Understanding HTLV-1 Induced Cancer: From Molecular Pathways to Treatment Strategies (Deadline: 25 August 2026)
- Human Carcinogens—Chemical Agents, Occupational Exposure and Health Impact (Deadline: 31 August 2026)
- The Unseen Burden: Incidence and Outcomes of Infections in Leukemia (Deadline: 31 August 2026)
- Papillomaviruses and Cancer (Deadline: 30 September 2026)
- Infectious Pathogens and Cancer (Deadline: 25 November 2026)
- HCC Associated with Viral Liver Infections (HBV, HCV, and HDV) and Other Rare Conditions (Deadline: 11 December 2026)
- Retroviruses and Cancer Development: Molecular Mechanisms and Therapeutic Prospects (Deadline: 20 December 2026)
- Tumor–Microbiota Crosstalk: Immune Modulation and Resistance to Cancer Therapies (Deadline: 25 December 2026)
- Feature Papers in Section “Infectious Agents and Cancer” (Deadline: 25 March 2027)
